Navigation Links
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Date:5/22/2013

to noon (CDT) in S 405Presented:Saturday, June 1, noon to 1 p.m. (CDT) in S 406 

About QuizartinibQuizartinib (AC220) is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently under evaluation in a Phase 2b clinical trial as monotherapy treatment for adult patients with relapsed or refractory AML, and in two Phase 1 studies in a combination treatment regimen with chemotherapy, and as a maintenance therapy following transplant, respectively.

About Ambit BiosciencesAmbit is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. Ambit's lead drug candidate, quizartinib (AC220), is a once-daily, orally-administered potent and selective, inhibitor of FMS-like tyrosine kinase-3 (FLT3) and is currently under clinical development in patients with relapsed/refractory acute myeloid leukemia (AML) and in newly diagnosed AML patients in combination with chemotherapy as well as maintenance following a hematopoietic stem cell transplantation (HSCT). In addition to quizartinib, Ambit's clinical pipeline includes AC410, an oral JAK2 inhibitor, and CEP-32496, a BRAF inhibitor licensed to Teva Pharmaceutical Industries Ltd. Ambit's preclinical portfolio includes a proprietary CSF1R inhibitor program.

Forward-Looking StatementsStatements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Ambit's expectations regarding future therapeutic and commercial potential of Ambit's lead drug candidate and pipeline, business plans, technologies and intellectual property. Because such statements are subject to risks and uncertainties, actual results may diffe
'/>"/>

SOURCE Ambit Biosciences Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
2. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
3. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
4. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
5. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
6. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
10. Neurocrine Biosciences Reports First Quarter 2012 Results
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... BOSTON , Aug. 29, 2014   Vittamed Corporation ... Boston announced today that T. (Teo) Forcht ... to the company,s Board of Directors. " ... distinguished career in neurosurgery, medical innovation and venture capital," said ... are extremely delighted to add his clinical, strategic, and entrepreneurial ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
(Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
... Acquire Next Generation Molecule GRC 6211 for the Potential ... Treatment of Pain, Including Osteoarthritic Pain, INDIANAPOLIS and MUMBAI, ... ) today announced that it has entered into an,agreement with ... Limited India (GPL). Under the terms,of the agreement, Lilly will ...
... MedImmune today announced,results from a recent economic ... is the standard of care for prevention of,severe ... virus,(RSV) in high- risk infants. Released at the ... Exhibition, the analysis evaluated the,costs of providing Synagis ...
Cached Medicine Technology:Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 2MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 3
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... 01, 2014 The Outlier Series announced ... exclusive interview content from one of the exceptional women ... Outliers: Women Game Changers . The title of the ... Game Changer Jenny McClendon . McClendon is currently a ... formerly the star of WeTV show, Raising Sextuplets. , ...
(Date:9/1/2014)... September 01, 2014 Beginning Tuesday, September ... 3,000 medical professionals and 10,000 consumers for the annual ... 5-day gathering of the nation’s top medical professionals who ... or conditions. The week-long event contains more than 120 ... instruction available in the pain management field. , MarijuanaDoctors.com ...
(Date:8/31/2014)... 31, 2014 MYMOBILEUNI (MMU) strategy ... social media marketing tools access to digital, resources, ... will utilize all tools to reach and collaborate ... our multiple learning channels. , MMU, today announced ... an authoring tool that applies social networking concepts ...
(Date:8/31/2014)... 01, 2014 GoDaddy, IX Web ... provide VPS (Virtual Private Server) hosting, which is ... into many servers, each of which has the ... dedicated computer. Top10BestSEOHosting.com has recently compared many professional ... companies are the best VPS hosting suppliers in ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2
... New Building provides Medical Office space for Doctors, Healthcare ... Specialists, and Medical Professionals, ... for medical space in the Near West Suburban market with ... square,feet of class A, medical office space available in Oakbrook ...
... September 2007. New Phase II data presented today suggest ... treatment of men with Hormone Resistant Prostate Cancer (HRPC), ... men with metastatic HRPC who were asymptomatic or mildly ... experienced a 45 percent reduction in the risk of ...
... Than Half Find Sex Lives Exciting, ATLANTA, Sept. ... themselves (i), but less than one hour on foreplay ... their love lives as,exciting. And while there are ... quality and quantity. On average, Americans spend 35 ...
... the country,s,largest hot tub retailer, announced that it ... give specially-designed therapeutic hot tubs to in 2008.,Through ... will donate 12,ThermoSpas hot tubs -- one a ... warm water therapy. ThermoSpas encourages parents, teachers and,friends ...
... PRAI ) announced today that it plans to relocate ... area by the end of,2007. "The current headquarters ... operational functions," said Terrance J.,Bieker, chief executive officer. "After ... the Raleigh area will allow,PRA to tap into a ...
... Selects Ericom(R) PowerTerm(R) WebConnect for ... ... Health Partners, a,New York-based non-profit hospital system, has chosen PowerTerm ... to,provide doctors and staff with secure, on-demand remote access to ...
Cached Medicine News:Health News:Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 2Health News:Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 3Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 2Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 3Health News:Americans Not Making Time for Making Love 2Health News:Americans Not Making Time for Making Love 3Health News:Americans Not Making Time for Making Love 4Health News:Photos: America's Chronically Ill Children Have New Hope with 'Hot' Gift 2Health News:PRA International Relocating Headquarters to Raleigh 2Health News:PRA International Relocating Headquarters to Raleigh 3Health News:Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization 2
The Pe-Plus offers an additional clinical option for replacing the acetabulum....
... Metal material and modularity into ... a fusion of technology and versatility ... for initial and long-term stability, but ... shell and liner options to address ...
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
Medicine Products: